SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NexStar Pharm(NXTR)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
328 5 0 NXTR
Emcee:  Miljenko Zuanic Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
253 FYI NEXSTAR PHARMACEUTICALS, INC. VICE PRESIDENT FILES SEC FORM 4 DecemberMichael-12/17/1997
252 Peter: From the last conference call NXTR CEO projected 3-3.5 M in revenue froMiljenko Zuanic-12/11/1997
251 Miljenko: I agree the drug is a solid improvement over Ampho B. I think (hope)Biomaven-12/11/1997
250 Peter: >>Nothing that looked too spectacular to me. I guess that the redMiljenko Zuanic-12/10/1997
249 Miljenko, In case you didn't see it yet, more Ambisome data from the confeBiomaven-12/10/1997
248 Peter and others: I guess the news on Abelcet, from ASH conference, contributeMiljenko Zuanic-12/8/1997
247 Thanks I would appreciate anything you can forward.Bill Tomko-11/25/1997
246 Hi Bill: >>Aren't the NXTR lipo. much smaller spheres then the SEQU Miljenko Zuanic-11/24/1997
245 Thanks for your responce. I found it helpful in getting a basic understanding. Bill Tomko-11/24/1997
244 Hi Bil: Glad to see you around. I guess you are referring to liposomal technoMiljenko Zuanic-11/19/1997
243 Cna anyone on this thread explain or reference me to a cite which will explain Bill Tomko-11/19/1997
242 Peter: IMO, Mikasome deserve better PR presentation from NXTR, similar to one Miljenko Zuanic-11/19/1997
241 Miljenko: I agree this release is not very well written. My interpretation: BBiomaven-11/18/1997
240 Peter: I guess NXTR followers disappeared after last deep. Yesterday I was waMiljenko Zuanic-11/17/1997
239 News on SELEX: ( BW)(NEXSTAR-PHARMA)(NXTR) NeXstar Pharmaceuticals Announces SMiljenko Zuanic-11/11/1997
238 Peter, Thanks for respond. You did clear (and confirm) few things in my mind. Miljenko Zuanic-11/2/1997
237 Miljenko, This filing reflects the ongoing distribution of the NXTR stock heldBiomaven-11/2/1997
236 Peter: Last SEC file (13D/A) by Warburg. edgar-online.com Does this have anyMiljenko Zuanic-11/2/1997
235 Miljenko, I'm optimistic about the Amphotericin B v. Ambisome battle. I woBiomaven-11/1/1997
234 Hi Amateur: Glad that somebody share similar view on NXTR. On the other hand, Miljenko Zuanic-10/31/1997
233 Miljenko: I got your e-mail however, I can't mail out yesterday or today. Joe Wesley-10/31/1997
232 Steven: Thanks for conference call number. I listen two times to be sure that Miljenko Zuanic-10/26/1997
231 Steven, Thanks for your post of playback number. I did listen to it. Here isHong-Lee Yu-10/25/1997
230 To NXTR investors: FYI, I was told that NXTR's conference call playback nuSteven Yang-10/24/1997
229 katy doherty @NXTR told mike hart@ imhof?Capevet-10/24/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News